Composite containing anti-PD-1 gene and polycation and its application in treating cancer
Patent Information
- Authority / Receiving Office
- CN Ā· China
- Current Assignee / Owner
- SHANGHAI YUNSHUN BIOTECH
- Publication Date
- 2017-02-22
- Estimated Expiration
- Not applicable Ā· inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the technical field of tumor treatment, in particular to a compound containing anti-PD-1 gene and polycation and its application in treating tumors, in particular to a compound containing anti-PD-1 (programmed death-1) gene The nanocomplex formed with polycations is transfected into T cells in vitro to prepare self-secreting anti-PD-1 antibody-T cells, which can produce PD-1 antibodies, thereby helping to block PD-1 signaling, which can effectively help exhausted T cells Cells, a method of treating tumors with T cells that promote anti-tumor immune responses. Background technique
[0002] T lymphocytes target and kill tumor cells expressing this specific antigen. Because of its ability to target and kill tumor cells, CTL therapy has become an ideal solution for individualized tumor treatment, and has received more and more attention from immunologists internationally. But T cells are inactivated due to the production ...